Repository logo
Andean Publishing ↗
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Autor "REC Wildman"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Supplemental Data - Mood and sleep outcomes following daily 5-hydroxytryptophan (derived from Griffonia simplicifolia) supplementation in healthy young adults: a randomized, double-blind, placebo-controlled trial
    (European Organization for Nuclear Research, 2026) Rachel Nye Venter; REC Wildman; Mark Haub; Michael C. Riddell; Chandradhara Divya
    The supplementary materials include additional safety and clinical assessment data supporting the findings of this randomized, double-blind, placebo-controlled trial. Supplementary Table S1 presents changes in vital signs (oral temperature, heart rate, systolic and diastolic blood pressure) from baseline (Day 0) to study completion (Day 25). Supplementary Table S2 reports hematological parameters assessed at baseline and Day 25. Supplementary Table S3 provides serum chemistry markers related to liver and kidney function measured at baseline and study completion. Collectively, these data support the short-term tolerability and safety of 5-HTP (from Griffonia simplicifolia) supplementation in the study population.
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Supplemental Data - Mood and sleep outcomes following daily 5-hydroxytryptophan (derived from Griffonia simplicifolia) supplementation in healthy young adults: a randomized, double-blind, placebo-controlled trial
    (European Organization for Nuclear Research, 2026) Rachel Nye Venter; REC Wildman; Mark Haub; Michael C. Riddell; Chandradhara Divya
    The supplementary materials include additional safety and clinical assessment data supporting the findings of this randomized, double-blind, placebo-controlled trial. Supplementary Table S1 presents changes in vital signs (oral temperature, heart rate, systolic and diastolic blood pressure) from baseline (Day 0) to study completion (Day 25). Supplementary Table S2 reports hematological parameters assessed at baseline and Day 25. Supplementary Table S3 provides serum chemistry markers related to liver and kidney function measured at baseline and study completion. Collectively, these data support the short-term tolerability and safety of 5-HTP (from Griffonia simplicifolia) supplementation in the study population.

Andean Library © 2026 · Andean Publishing

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback